InsiderTrades

Form 4 for RYAM RAYONIER ADVANCED MATERIALS INC.

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001225208-23-003369 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 RYAM Ribeyrolle Christian Antoine Lucien VP, Biomaterials A - Grant $0.00 +4,805 8,730 +122% $0
D 2023-03-03 2023-03-01 RYAM Ribeyrolle Christian Antoine Lucien VP, Biomaterials M - OptEx $0.00 +3,334 12.1K +38% $0
D 2023-03-03 2023-03-01 RYAM Ribeyrolle Christian Antoine Lucien VP, Biomaterials M - OptEx $0.00 -3,334 0 -100% $0
D 2023-03-03 2023-03-01 RYAM Ribeyrolle Christian Antoine Lucien VP, Biomaterials A - Grant $0.00 +8,940 8,940 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 A A 4,805 $0.00 8,730 D — — (F1) Paid pursuant to 2020 Performance Share Unit Award Agreement.
2 Common Common Stock 2023-03-01 M A 3,334 $0.00 12,064 D — —
3 Derivative Restricted Stock Units 2023-03-01 M D 3,334 $0.00 0 D — · 2023-03-02 to 2023-03-02 3,334 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of RYAM common stock. (F3) Due to an administrative error the exercisable date and the expiration date were incorrectly reported as March 2, 2023 instead of March 1, 2023.
4 Derivative Restricted Stock Units 2023-03-01 A A 8,940 $0.00 8,940 D — · 2026-03-01 to 2026-03-01 8,940 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.